Pharmacy Trial Program - Continuing Community Pharmacy Programs

The Sixth Agreement has a primary focus on assisting patients better manage their medications thereby reducing medication misadventure and delivering primary healthcare services through community pharmacy.

Page last updated: 08 March 2017

Under the Sixth Agreement, $613 million has been allocated to support community pharmacy programs that are continuing from the Fifth Community Pharmacy Agreement. These programs are listed below;

  • Dose Administration Aids
  • Staged Supply
  • Clinical Interventions
  • Home Medicines Reviews
  • Residential Medication Management Reviews
  • MedsCheck and Diabetes MedsCheck
  • Rural Pharmacy Workforce Program
  • Rural Pharmacy Maintenance Allowance
  • Aboriginal and Torres Strait Islander Specific Programs
  • Electronic Prescription Fee
All continuing community programs and services will be assessed for clinical and cost effectiveness by an independent health technology assessment body, such as the Medical Services Advisory Committee. The Trials Advisory Group may also provide advice on any evidence generation processes required to inform cost-effectiveness assessments.

This process will ensure community pharmacy programs and services are assessed against the same standards of evidence as for other health professions. It supports a consistent approach to informing investment that delivers the greatest benefit to consumers, and will include existing programs and services, as well as investment in a range of new programs and services delivered through community pharmacy.

For more information on the community pharmacy programs, please visit Community Pharmacy Programs.